MetLife Résultats passés
Passé contrôle des critères 1/6
Les bénéfices de MetLife ont diminué à un taux annuel moyen de -8%, tandis que le secteur Insurance a vu ses bénéfices augmenter de en à 14.6% par an. Les revenus ont augmenté de en à un taux moyen de 1.9% par an. Le rendement des capitaux propres de MetLife est 13% et ses marges nettes sont de 4.4%.
Informations clés
-8.02%
Taux de croissance des bénéfices
-1.48%
Taux de croissance du BPA
| Insurance Croissance de l'industrie | 8.02% |
| Taux de croissance des recettes | 1.87% |
| Rendement des fonds propres | 13.00% |
| Marge nette | 4.43% |
| Dernière mise à jour des bénéfices | 31 Mar 2026 |
Mises à jour récentes des performances passées
Recent updates
Seeking Alpha • May 24
MetLife: Time To Go Long The Common Shares And 6.35% Yielding Preferreds
Summary MetLife delivers robust adjusted income, supporting a bullish stance on common shares and fixed-rate preferreds. MET's preferred dividend payout ratio remains low, with $24.5B in common equity providing strong downside protection for preferred holders. Series A floating-rate preferreds yield 5.45%-5.5%, attractive if short-term rates rise, but fixed-rate Series F offers a higher current yield. I rate MET common and Series F preferreds as a "buy," maintaining "hold" on Series A preferreds pending a significant SOFR increase. Read the full article on Seeking Alpha
Mise à jour du récit • May 03
MET: Share Repurchases And Dividend Increases Will Support Future Upside Potential
Analysts have slightly adjusted their fair value estimate for MetLife, nudging the implied price target from about $89.06 to $89.31. This reflects modest tweaks to assumptions around the discount rate, long term revenue growth, profit margin and future P/E multiples.Mise à jour du récit • Apr 17
MET: Share Repurchases Following Index Exit Will Support Future Upside Potential
Analysts have slightly reduced their MetLife fair value estimate to $89.06 from $90.50, reflecting minor adjustments to assumptions for the discount rate, revenue growth, profit margin, and future P/E ratio that refine their outlook for the shares. What's in the News MetLife has been dropped from the S&P 100 index, which may influence how some index funds and benchmarks gain exposure to the stock (Key Developments).Mise à jour du récit • Apr 01
MET: Share Repurchases And Index Exit Will Shape Future Upside Potential
Analysts have trimmed their average MetLife price target slightly to $90.50 from $90.73, citing updated views on revenue growth, profit margins, and future P/E assumptions. What's in the News MetLife, Inc.Mise à jour du récit • Mar 18
MET: Share Repurchases Will Support Future Upside Potential
Analysts have slightly adjusted their price target for MetLife to $90.73 from $90.93, reflecting updated views on discount rates, revenue growth, profit margins, and future price-to-earnings (P/E) assumptions. What's in the News MetLife reported that from October 1, 2025 to January 31, 2026 it repurchased 7,608,263 shares, representing 1.15% of shares, for a total of US$600 million under its current buyback program (Key Developments).Mise à jour du récit • Mar 04
MET: Buybacks And Retirement Income Agreements Will Drive Future Upside
Analysts have trimmed their price target on MetLife to about $90.93 from roughly $92.93. This reflects updated views on slightly lower expected revenue growth, a modestly softer profit margin, a higher discount rate, and a largely unchanged future P/E assumption.Mise à jour du récit • Dec 16
MET: Retirement Income Agreements Will Drive Future Upside In Earnings Power
Analysts have marginally reduced their price target on MetLife to approximately 92.93 dollars from 93 dollars, citing a slightly higher assumed discount rate. This more than offsets modest improvements in forecast profit margins and valuation multiples.Mise à jour du récit • Nov 07
MET: Revenue Will Advance On New Retirement Income And Employee Support Agreements
Analysts have slightly reduced their price target for MetLife from $93.33 to $93.00, reflecting minor adjustments to discount rate and profit margin assumptions. They maintain a positive outlook on revenue growth.Mise à jour du récit • Oct 24
Digital Expansion And Employee Support Benefits Will Drive Outperformance Ahead
Analysts have modestly raised their price target for MetLife, increasing it from $93.00 to $93.33 per share. They cited slight improvements in projected revenue growth and profit margins as the reason for the adjustment.Mise à jour du récit • Oct 09
International Demand And Digital Transformation Will Fuel Success
Analysts have raised their fair value estimate for MetLife from $91.86 to $93.00. This reflects slight adjustments to discount rates and growth assumptions.Mise à jour du récit • Sep 04
International Demand And Digital Transformation Will Fuel Success
With no change in revenue growth forecasts or discount rate, MetLife’s fair value estimate remains steady at $91.86. What's in the News MetLife will redeem all outstanding shares of its 3.850% Fixed Rate Reset Non-Cumulative Preferred Stock, Series G, at $1,000 per share; dividends of $19.250 per share will be paid separately, and all further dividends cease post-redemption.Article d’analyse • Jun 11
It's Unlikely That MetLife, Inc.'s (NYSE:MET) CEO Will See A Huge Pay Rise This Year
Key Insights MetLife's Annual General Meeting to take place on 17th of June Salary of US$1.50m is part of CEO Michel...Seeking Alpha • Feb 11
MetLife: Double-Digit EPS Growth With A Single-Digit P/E, Strong Chart
Summary MetLife, Inc. is rated a buy due to its solid value, above-market dividend yield, and favorable technical chart despite recent earnings misses. Insurance stocks, including MET, have lagged behind the Financials sector and S&P 500, with premium increases expected to slow as consumers react to rising costs. MET's 2025 outlook is positive, with analysts forecasting over 17% EPS growth and 5%-6% revenue growth, despite recent underperformance in certain segments. Key risks include lower stock prices, falling interest rates, and regulatory challenges, but MET's strong investment income and share buybacks are positive factors. Read the full article on Seeking AlphaSeeking Alpha • Nov 26
MetLife Upgraded To Buy As Financials And Insurance Show Further Upside Potential
Summary MetLife stock gets upgraded to a buy, from my prior hold rating, as indicators point to further share price potential in the financials sector, as well as the insurance subsector. Data points to future continued demand for annuities and life insurance, and MetLife has in Q3 achieved new organic customer growth in 2 key businesses. Although its dividend yield is not stellar vs. peers, it has a 10-year track record of proven dividend growth, something it has potential to continue. Even though it is trading at a 10-year high, it remains undervalued on P/E and EV/EBITDA vs. peers, so continues to present a buy opportunity. Read the full article on Seeking AlphaSeeking Alpha • Sep 23
MetLife: One Of The Best Life Insurance Stocks
Summary MetLife's strong financial performance, with a 17.5% increase in adjusted EPS and a 15.2% rise in book value, makes it an attractive investment. Despite comparable performance to Aflac, MetLife's lower valuation offers better value for shareholders. MetLife's growing dividend yield and robust share buyback program enhance shareholder value, with ample cash reserves supporting future buybacks. Risks include potential commercial real estate portfolio defaults and market volatility, but MetLife's strong fundamentals and attractive valuation make it a compelling choice. Read the full article on Seeking AlphaSeeking Alpha • Jul 09
Higher For Longer? Consider MetLife's Preferred Shares With A 6.6% Yield
Summary MetLife's preferred shares, particularly the Series A with floating dividends, offer potential for investors in a 'higher for longer' inflation and interest rate environment. MetLife's strong financial performance in Q1 2021, with net profit covering preferred dividends by less than 8%. Series A preferred shares have a minimum 4% floor for dividends, with potential for higher yields based on 3 month SOFR rate adjustments. Read the full article on Seeking AlphaSeeking Alpha • Jun 26
MetLife Looks Like An Undervalued Property In An Unpopular Neighborhood
Summary MetLife shares have outperformed peers, but life insurance stocks have not really been in favor given concerns about CRE losses and rate cuts. Higher rates have allowed MetLife to reprice its investment portfolio at higher rates and sell more spread products, and the benefits will last even as rates fall. There are understandable concerns about MetLife's CRE exposure (office in particular), as the insurer is overweight here, but losses will take years to materialize and can be absorbed. MetLife's focus on profitable core businesses like group life and health, pension risk transfer, and international markets should lead to steady growth and returns for investors. This is something of a contrarian call given weak sector sentiment, but MetLife's differentiated model and ability to out-earn its cost of equity should drive outperformance. Read the full article on Seeking AlphaSeeking Alpha • Apr 18
MetLife: Healthy But Lacks Clear Advantages
Summary MetLife has experienced a decade of light shrinking instead of growth. This started as early as 2015 and was attributed to increased competition and a decrease in annuity sales, but this never seemed to improve. With their current size, competitive hurdles, and lack of clear targets for growth internationally, shares of MET will likely only give mediocre returns at best. Read the full article on Seeking AlphaVentilation des recettes et des dépenses
Ventilation des recettes et des dépenses
Comment MetLife gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
| Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
|---|---|---|---|---|
| 31 Mar 26 | 77,584 | 3,434 | 0 | 0 |
| 31 Dec 25 | 77,079 | 3,173 | 0 | 0 |
| 30 Sep 25 | 71,932 | 3,634 | 0 | 0 |
| 30 Jun 25 | 73,011 | 4,091 | 0 | 0 |
| 31 Mar 25 | 73,494 | 4,305 | 0 | 0 |
| 31 Dec 24 | 70,982 | 4,226 | 0 | 0 |
| 30 Sep 24 | 71,340 | 3,561 | 0 | 0 |
| 30 Jun 24 | 68,767 | 2,708 | 0 | 0 |
| 31 Mar 24 | 67,570 | 2,166 | 0 | 0 |
| 31 Dec 23 | 66,901 | 1,380 | 0 | 0 |
| 30 Sep 23 | 63,479 | 2,355 | 0 | 0 |
| 30 Jun 23 | 69,896 | 3,031 | 0 | 0 |
| 31 Mar 23 | 68,747 | 3,542 | 0 | 0 |
| 31 Dec 22 | 68,764 | 5,099 | 0 | 0 |
| 30 Sep 22 | 73,251 | 4,726 | 0 | 0 |
| 30 Jun 22 | 67,873 | 5,149 | 0 | 0 |
| 31 Mar 22 | 70,923 | 7,634 | 0 | 0 |
| 31 Dec 21 | 68,688 | 6,654 | 0 | 0 |
| 30 Sep 21 | 70,409 | 5,301 | 0 | 0 |
| 30 Jun 21 | 69,519 | 4,413 | 0 | 0 |
| 31 Mar 21 | 65,094 | 1,115 | 0 | 0 |
| 31 Dec 20 | 67,842 | 5,191 | 0 | 0 |
| 30 Sep 20 | 65,567 | 5,603 | 0 | 0 |
| 30 Jun 20 | 68,230 | 7,122 | 0 | 0 |
| 31 Mar 20 | 71,628 | 8,738 | 0 | 0 |
| 31 Dec 19 | 69,620 | 5,721 | 0 | 0 |
| 30 Sep 19 | 68,139 | 7,195 | 0 | 0 |
| 30 Jun 19 | 65,750 | 5,923 | 0 | 0 |
| 31 Mar 19 | 69,438 | 5,084 | 0 | 0 |
| 31 Dec 18 | 67,941 | 4,982 | 0 | 0 |
| 30 Sep 18 | 68,112 | 5,244 | -252 | 0 |
| 30 Jun 18 | 67,980 | 5,235 | -166 | 0 |
| 31 Mar 18 | 62,119 | 5,197 | 0 | 0 |
| 31 Dec 17 | 62,308 | 4,893 | 0 | 0 |
| 30 Sep 17 | 59,263 | 1,893 | -33 | 0 |
| 30 Jun 17 | 58,908 | 2,044 | -28 | 0 |
| 31 Mar 17 | 57,263 | 2,229 | -97 | 0 |
| 31 Dec 16 | 60,732 | 3,481 | 0 | 0 |
| 30 Sep 16 | 65,209 | 4,994 | 368 | 0 |
| 30 Jun 16 | 67,255 | 5,169 | 355 | 0 |
| 31 Mar 16 | 69,952 | 5,219 | 342 | 0 |
| 31 Dec 15 | 61,257 | 3,891 | 0 | 0 |
| 30 Sep 15 | 71,888 | 5,857 | 333 | 0 |
| 30 Jun 15 | 72,677 | 6,724 | 350 | 0 |
Des revenus de qualité: MET a des bénéfices de haute qualité.
Augmentation de la marge bénéficiaire: Les marges bénéficiaires nettes actuelles de MET sont inférieures à celles de l'année dernière MET. (4.4%) sont inférieures à celles de l'année dernière (5.9%).
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: Les bénéfices de MET ont diminué de 8% par an au cours des 5 dernières années.
Accélération de la croissance: MET a connu une croissance négative de ses bénéfices au cours de l'année écoulée, elle ne peut donc pas être comparée à sa moyenne sur 5 ans.
Bénéfices par rapport au secteur d'activité: MET a enregistré une croissance négative de ses bénéfices ( -20.2% ) au cours de l'année écoulée, ce qui rend difficile la comparaison avec la moyenne du secteur Insurance ( 36.5% ).
Rendement des fonds propres
ROE élevé: Le retour sur capitaux propres de MET ( 13% ) est considéré comme faible.
Rendement des actifs
Rendement des capitaux employés
Découvrir des entreprises performantes dans le passé
Analyse de l'entreprise et données financières
| Données | Dernière mise à jour (heure UTC) |
|---|---|
| Analyse de l'entreprise | 2026/05/26 06:32 |
| Cours de l'action en fin de journée | 2026/05/22 00:00 |
| Les revenus | 2026/03/31 |
| Revenus annuels | 2025/12/31 |
Sources de données
Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.
| Paquet | Données | Cadre temporel | Exemple de source américaine * |
|---|---|---|---|
| Finances de l'entreprise | 10 ans |
| |
| Estimations consensuelles des analystes | +3 ans |
|
|
| Prix du marché | 30 ans |
| |
| Propriété | 10 ans |
| |
| Gestion | 10 ans |
| |
| Principaux développements | 10 ans |
|
* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.
Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.
Modèle d'analyse et flocon de neige
Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github; nous proposons également des guides expliquant comment utiliser nos rapports et des tutoriels sur Youtube.
Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.
Indicateurs de l'industrie et du secteur
Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.
Sources des analystes
MetLife, Inc. est couverte par 32 analystes. 9 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.
| Analyste | Institution |
|---|---|
| Jacob Kilstein | Argus Research Company |
| Jay Gelb | Barclays |
| Taylor Scott | Barclays |